Effects of estrogen plus progestin on health-related quality of life.
By A. A. Lopes, A. Latado, G. B. Lopes. New England Journal of Medicine, 2004
651 citations recorded by the source corpus.
Subfields: Endocrinology, Diabetes and Metabolism, Genetics, Pathology and Forensic Medicine
View Paper: https://www.semanticscholar.org/paper/135473e5582d883dadf49fa07512924fd163e654
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Endocrinology, Diabetes and Metabolism
In Pathology and Forensic Medicine
Citations in the corpus
- Effect of estrogen plus progestin on global cognitive function in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. (2003, methodology): “In the analysis of 3MSE scores in the entire cohort of women aged 65 years or older in the WHI estrogen plus progestin trial, score changes did not differ significantly over 1 or 3 years.(20) In the current WHIMS cohort, 4381 women provided baseline and at least 1 follow-up score on the 3MSE.”
- European guidance for the diagnosis and management of osteoporosis in postmenopausal women (2008, background): “There was also a slight increase in the risk of dementia [235] and no clinically meaningful effect on health-related quality of life such as sleep disturbance or vasomotor symptoms [236].”
- Effects of estrogen plus progestin on risk of fracture and bone mineral density: the Women's Health Initiative randomized trial. (2003, background): “In a separate analysis, the overall balance of risks and benefits of hormone therapy on quality of life did not show a clinically significant benefit.(36) In conclusion, estrogen plus progestin increases BMD and reduces the risk of fracture in healthy postmenopausal women and appears to do so regard”